Toggle navigation
Home
Search
Services
Blog
Contact
About
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Drug Free Communities Support Program
Chamomile as Medicine for Prostate cancer
Cell Contact Induced Drug Resisatence
Mechanisms of Arsine Gas and Gallium Arsenide Toxicity
Deployment of Seafloor Optical Fiber Strainmeters for the Detection of Slow Slip Events
Recently added grants:
High Throughput screen to identify 'first of their kind' activators of ADCY10
Autonomous and Non-Autonomous Regulation of Cardiac Aging
Drug interactions involving psychoactive drugs
Regulation of Mitochondrial DNA-Mediated Signaling and Its Contribution to Cellular and Organismal Aging
Regulation of the follicular T-cell response to autoimmunity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025011-000
Application #
6688657
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant